Why Scientists Should Start Playing The Political Game

The National Academy of Sciences’ recent report on the behavioral and social sciences reveals that federal support of this domain of science has declined over the past 16 years, even though support for other areas of science has grown substantially. The report makes a good case for the public benefits of research in behavioral and social sciences and argues for increased funding. This argument, however, is likely to fall on deafened ears, as almost every segment of the scientific communi

Written byDismukes
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

The National Academy of Sciences’ recent report on the behavioral and social sciences reveals that federal support of this domain of science has declined over the past 16 years, even though support for other areas of science has grown substantially. The report makes a good case for the public benefits of research in behavioral and social sciences and argues for increased funding. This argument, however, is likely to fall on deafened ears, as almost every segment of the scientific community has pleaded for more funds in recent years.

What can behavioral and social scientists—or, for that matter, any other scientific disciplines in similar straits—do to promote their case better? The answer lies in recognizing the political realities of science funding. We cannot escape the fact that conducting research, however pioneering and important, is simply not enough to ensure fiscal health. Scientists must also play a political game to win friends ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies